See analyst estimates and all valuation multiples for Health & Beauty
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $446B | 7.5x | 16.3x | |
| $397B | 4.7x | 16.9x | |
| $241B | 4.7x | 19.5x | |
| $177B | 2.6x | 12.0x | |
| $73.4B | 3.6x | 14.8x | |
| $69.2B | 1.3x | 6.1x | |
| $67.2B | 9.2x | 40.2x | |
| $63.3B | 3.3x | 11.8x | |
| $51.6B | 3.4x | 13.7x | |
| $45.1B | 9.1x | 39.5x | |
| $43.8B | 4.7x | 19.2x | |
| $42.5B | 2.8x | 12.2x | |
| $38.4B | 2.7x | 18.9x | |
| $34.0B | 1.4x | 7.6x | |
| $25.6B | 2.2x | 14.4x | |
| $23.6B | 3.8x | 16.8x | |
| $22.4B | 2.2x | 6.5x | |
| $21.1B | 1.8x | 10.4x | |
| $21.1B | 1.4x | 7.6x | |
| $20.5B | 1.8x | 12.1x | |
| $14.5B | 8.5x | 40.5x | |
| $12.8B | 2.2x | 15.5x | |
| $12.7B | 8.4x | 32.9x | |
| $10.9B | 1.9x | 9.4x | |
| $10.6B | 7.2x | 38.4x | |
| $10.3B | 7.7x | 40.5x | |
| $9.5B | 1.4x | 8.1x | |
| $8.3B | 5.6x | 25.8x | |
| $8.3B | 1.3x | 12.0x | |
| $7.8B | 1.3x | 7.3x | |
| $7.2B | 10.4x | 32.0x | |
| $6.8B | 7.5x | 17.6x | |
| $6.1B | 1.4x | 8.2x | |
| $5.8B | 6.8x | 27.8x | |
| $5.6B | 2.0x | 8.7x | |
| $5.1B | 1.7x | 11.5x | |
| $5.0B | 11.3x | 35.6x | |
| $4.9B | 4.4x | 28.1x | |
| $4.9B | 9.8x | 39.5x | |
| $4.0B | 1.9x | 11.6x | |
| $4.0B | 3.6x | 10.8x | |
| $4.0B | 2.5x | 13.2x | |
| $4.0B | 1.2x | 7.0x | |
| $3.7B | 1.2x | 7.2x | |
| $3.7B | 1.7x | 10.2x | |
| $3.6B | 11.2x | 42.3x | |
| $3.4B | 2.3x | 11.8x | |
| $3.4B | 4.5x | 21.5x | |
| $2.9B | 2.8x | 12.8x | |
| $2.9B | 6.5x | 24.2x | |
| $2.6B | 1.0x | 5.2x | |
| $2.6B | 0.6x | 6.1x | |
| $2.6B | 0.9x | 7.3x | |
| $2.5B | 3.1x | 20.5x | |
| $2.5B | 0.7x | 4.9x | |
| $2.4B | 2.1x | 16.2x | |
| $2.3B | 0.4x | 4.0x | |
| $2.3B | 1.1x | 8.7x | |
| $2.3B | 6.3x | 17.6x | |
| $2.3B | 1.3x | 10.9x | |
| $2.2B | 1.0x | 7.0x | |
| $2.1B | 3.6x | 18.8x | |
| $2.0B | 1.1x | 8.3x | |
| $2.0B | 1.8x | -106.7x | |
| $1.9B | 2.8x | 13.9x | |
| $1.8B | 0.8x | 8.6x | |
| $1.7B | 5.8x | 14.6x | |
| $1.5B | 1.2x | 8.6x | |
| $1.5B | 2.4x | 10.2x | |
| $1.4B | 0.8x | 5.7x | |
| $1.3B | 0.6x | 5.4x | |
| $1.3B | 1.7x | 7.1x | |
| $1.2B | 8.3x | 28.4x | |
| $1.1B | 4.3x | 84.2x | |
| $1.1B | 1.5x | 10.1x | |
| $1.0B | 2.4x | 10.0x | |
| $781M | 0.7x | 7.0x | |
| $780M | 1.0x | 5.4x | |
| $762M | n/a | n/a | |
| $760M | 1.7x | 8.2x | |
| $709M | n/a | n/a | |
| $651M | 0.2x | 1.7x | |
| $625M | 0.4x | n/a | |
| $619M | n/a | n/a | |
| $586M | 2.9x | -44.4x | |
| $568M | 1.4x | 9.1x | |
| $533M | 0.8x | 5.8x | |
| $515M | 1.8x | -33.3x | |
| $472M | 1.5x | 18.9x | |
| $443M | n/a | n/a | |
| $408M | 1.4x | 10.2x | |
| $390M | 1.0x | 14.1x | |
| $378M | 1.6x | n/a | |
| $369M | n/a | n/a | |
| $339M | 0.8x | 9.4x | |
| $274M | 1.1x | 11.4x | |
| $260M | n/a | n/a | |
| $251M | n/a | n/a | |
| $232M | 5.0x | 17.9x | |
| $229M | 0.4x | 11.3x | |
| $228M | 1.6x | 6.5x | |
| $207M | n/a | n/a | |
| $205M | 1.0x | 6.7x | |
| $197M | 1.0x | 4.8x | |
| $187M | 1.0x | 9.4x | |
| $185M | 2.3x | 12.9x | |
| $147M | n/a | n/a | |
| $139M | 0.5x | 6.3x | |
| $138M | 2.4x | 8.9x | |
| $101M | n/a | n/a | |
| $86.9M | 0.3x | 6.1x | |
| $82.0M | n/a | n/a | |
| $55.5M | 1.3x | n/a | |
| $45.4M | 1.9x | 7.3x | |
| $42.1M | n/a | n/a | |
| $38.8M | n/a | n/a | |
| $28.4M | n/a | n/a | |
| $23.8M | 1.8x | n/a | |
| $20.3M | 0.7x | -52.9x | |
| $19.9M | n/a | n/a | |
| $15.4M | n/a | n/a | |
| $13.3M | n/a | n/a | |
| $11.8M | n/a | n/a | |
| $8.2M | 0.0x | 0.6x | |
| $5.9M | n/a | n/a | |
| $1.4M | n/a | n/a | |
| -$3.9M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Health & Beauty